Blood Cancer Diagnostics Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022

  • Published : Jul-2017
  • Tables : 165
  • Figures : 57
  • Category : Healthcare
  • No. of Pages : 170
  • Report Code : FACT47MR
  • Format : ppt

Blood cancer diagnostics can be defined as the wide range of screening & diagnosis tests associated with blood cancers such as lymphoma, leukemia and myeloma. Bone marrow examination, blood sample tests, complete blood count tests, flow cytometry, cupping therapy and genetic testing are prominent procedures in the diagnosis of blood cancer.

Increase in the prevalence of oncological diseases and technological advancements in diagnostics are positively impacting the global blood cancer diagnostics market. Focus on detecting cancer at an early stage through molecular and RNA/DNA testing can widely improve the diagnosis. As spending on healthcare witnesses a gradual increase in developing countries, the overall blood cancer diagnostics market is projected to grow at a steady rate during the forecast period 2017-2022. According to Fact.MR’s analysis, the global blood cancer diagnostics market is projected to grow at a steady CAGR during the forecast period.

Fact.MR’s report offers market analysis and forecast on the global blood cancer diagnostics market on the basis of test type. Liquid biopsy is another test type that remains widely used among end-users. Studies have shown that liquid biopsy can overcome challenges related to intra- and inter-tumor heterogeneity. The research was carried out at Harvard Medical School and Massachusetts General Hospital Cancer Center. Inclusion of liquid biopsy can help in identifying resistance alternations in patients with advanced cholangiocarcinoma. On account of growing preference for liquid biopsy, this segment is projected to increase at a CAGR of over 10% through 2022.

Market Taxonomy

Test Type

End User

CBC Tests

Hospital Associated Labs

CTC Tests

Independent Diagnostic Laboratories

Blood Protein Testing

Cancer Research Institutes

Liquid Biopsy

Others

Bone Marrow Biopsy

 

Others

 

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

According to the report, the CBC test segment type of the global blood cancer market is valued at nearly US$ 77 million in 2017. By 2022, this is projected to grow at a healthy rate. The market in North America will remain lucrative for manufacturers throughout the forecast period. The CTC tests segment on the other hand, is anticipated to grow at a relatively higher CAGR than the CBC test segments.

Owing to accuracy and convenience of blood testing protein test type, it is anticipated that more end-use sectors will continue to use this type of testing globally. Fact.MR estimates the global blood protein testing market to rake in significant revenues during the forecast period.

By end-users, hospital associated labs account for a significant percentage of the global blood cancer diagnostics market. Valued at over US$ 136 million in 2017, the hospital associated labs segment is projected to surpass US$ 180 million in revenues by 2022. Demand from hospital associated labs segment is projected to grow at a steady CAGR during the forecast period.

Demand for blood cancer diagnostics is also significant from the independent diagnostic laboratories segment. According to Fact.MR’s research, the independent diagnostics laboratories segment is projected to grow steadily through 2022. Cancer research institutes are also a key end-user, and demand from this segment is projected to grow at healthy CAGR through 2022.

Competition Tracking

The key companies profiled in Fact.MR’s research include Abbott Laboratories, Roche Holding A.G., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Luminex Corporation, Myriad Genetics Inc., NanoString Technologies Inc, NeoGenomics Laboratories, Inc., Siemens AG, Quest Diagnostics Incorporated, Qiagen N.V., Agilent Technologies, Biotheranostics, Inc, Almac Group Limited, and GeneNews Limited.

Overall, the global blood cancer diagnostics market is anticipated to witness steady growth through 2022. The market will continue to be influenced by regulatory policies and guidelines.

Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR

Chapter 1. Global Blood Cancer Diagnostics Market - Executive Summary. 12

Chapter 2. Global Blood Cancer Diagnostics Market Overview. 14
2.1. Introduction. 14
       2.1.1. Global Blood Cancer Diagnostics Market Taxonomy. 14
       2.1.2. Global Blood Cancer Diagnostics Market Definition. 14
2.2. Global Blood Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2012-2022. 15
       2.2.1. Global Blood Cancer Diagnostics Market Y-o-Y Growth. 15
2.3. Global Blood Cancer Diagnostics Market Dynamics. 15
       2.3.1. Drivers. 15
       2.3.2. Restraints. 16
       2.3.3. Trends. 16
2.4. Supply Chain. 16
2.5. Epidemiology. 16
2.6. List of Distributors. 16
2.7. Average Pricing Analysis. 17
2.8. Regulations. 17
2.9. Key Participants Market Presence (Intensity Map) By Region. 17

Chapter 3. Global Blood Cancer Diagnostics Market Analysis and Forecast By Test Type. 18
3.1. Global Blood Cancer Diagnostics Market Size and Forecast By Test Type, 2012-2022. 18
       3.1.1. CBC Tests Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 18
                3.1.1.1. Revenue (US$ Mn) Comparison, By Region. 18
                3.1.1.2. Market Share Comparison, By Region. 20
                3.1.1.3. Y-o-Y growth Comparison, By Region. 20
       3.1.2. CTC Tests Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 21
                3.1.2.1. Revenue (US$ Mn) Comparison, By Region. 21
                3.1.2.2. Market Share Comparison, By Region. 23
                3.1.2.3. Y-o-Y growth Comparison, By Region. 23
       3.1.3. Blood Protein Testing Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 24
                3.1.3.1. Revenue (US$ Mn) Comparison, By Region. 24
                3.1.3.2. Market Share Comparison, By Region. 26
                3.1.3.3. Y-o-Y growth Comparison, By Region. 26
       3.1.4. Liquid Biopsy Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 27
                3.1.4.1. Revenue (US$ Mn) Comparison, By Region. 27
                3.1.4.2. Market Share Comparison, By Region. 29
                3.1.4.3. Y-o-Y growth Comparison, By Region. 29
       3.1.5. Bone Marrow Biopsy Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 30
                3.1.5.1. Revenue (US$ Mn) Comparison, By Region. 30
                3.1.5.2. Market Share Comparison, By Region. 32
                3.1.5.3. Y-o-Y growth Comparison, By Region. 32
       3.1.6. Others Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 33
                3.1.6.1. Revenue (US$ Mn) Comparison, By Region. 33
                3.1.6.2. Market Share Comparison, By Region. 35
                3.1.6.3. Y-o-Y growth Comparison, By Region. 35

Chapter 4. Global Blood Cancer Diagnostics Market Analysis and Forecast By End User. 37
4.1. Global Blood Cancer Diagnostics Market Size and Forecast By End User, 2012-2022. 37
       4.1.1. Hospital Associated Labs Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 37
                4.1.1.1. Revenue (US$ Mn) Comparison, By Region. 37
                4.1.1.2. Market Share Comparison, By Region. 39
                4.1.1.3. Y-o-Y growth Comparison, By Region. 39
       4.1.2. Independent Diagnostic Laboratories Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 40
                4.1.2.1. Revenue (US$ Mn) Comparison, By Region. 40
                4.1.2.2. Market Share Comparison, By Region. 42
                4.1.2.3. Y-o-Y growth Comparison, By Region. 42
       4.1.3. Cancer Research Institutes Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 43
                4.1.3.1. Revenue (US$ Mn) Comparison, By Region. 43
                4.1.3.2. Market Share Comparison, By Region. 45
                4.1.3.3. Y-o-Y growth Comparison, By Region. 45
       4.1.4. Others Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 46
                4.1.4.1. Revenue (US$ Mn) Comparison, By Region. 46
                4.1.4.2. Market Share Comparison, By Region. 48
                4.1.4.3. Y-o-Y growth Comparison, By Region. 48

Chapter 5. Global Blood Cancer Diagnostics Market Analysis and Forecast By Region. 50
5.1. Global Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 50
       5.1.1. North America Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 50
                5.1.1.1. Revenue (US$ Mn) Comparison, By Test Type. 50
                5.1.1.2. Revenue (US$ Mn) Comparison, By End User. 52
       5.1.2. Latin America Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 54
                5.1.2.1. Revenue (US$ Mn) Comparison, By Test Type. 54
                5.1.2.2. Revenue (US$ Mn) Comparison, By End User. 55
       5.1.3. Europe Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 57
                5.1.3.1. Revenue (US$ Mn) Comparison, By Test Type. 57
                5.1.3.2. Revenue (US$ Mn) Comparison, By End User. 59
       5.1.4. Japan Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 61
                5.1.4.1. Revenue (US$ Mn) Comparison, By Test Type. 61
                5.1.4.2. Revenue (US$ Mn) Comparison, By End User. 62
       5.1.5. APEJ Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 64
                5.1.5.1. Revenue (US$ Mn) Comparison, By Test Type. 64
                5.1.5.2. Revenue (US$ Mn) Comparison, By End User. 66
       5.1.6. MEA Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 67
                5.1.6.1. Revenue (US$ Mn) Comparison, By Test Type. 67
                5.1.6.2. Revenue (US$ Mn) Comparison, By End User. 69

Chapter 6. North America Blood Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022. 71
6.1. US Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 71
       6.1.1. Revenue (US$ Mn) Comparison, By Test Type. 71
       6.1.2. Revenue (US$ Mn) Comparison, By End User. 72
6.2. Canada Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 73
       6.2.1. Revenue (US$ Mn) Comparison, By Test Type. 73
       6.2.2. Revenue (US$ Mn) Comparison, By End User. 74

Chapter 7. Latin America Blood Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022. 75
7.1. Brazil Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 75
       7.1.1. Revenue (US$ Mn) Comparison, By Test Type. 75
       7.1.2. Revenue (US$ Mn) Comparison, By End User. 76
7.2. Mexico Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 77
       7.2.1. Revenue (US$ Mn) Comparison, By Test Type. 77
       7.2.2. Revenue (US$ Mn) Comparison, By End User. 78
7.3. Argentina Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 79
       7.3.1. Revenue (US$ Mn) Comparison, By Test Type. 79
       7.3.2. Revenue (US$ Mn) Comparison, By End User. 80

Chapter 8. Europe Blood Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022. 81
8.1. Germany Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 81
       8.1.1. Revenue (US$ Mn) Comparison, By Test Type. 81
       8.1.2. Revenue (US$ Mn) Comparison, By End User. 82
8.2. UK Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 83
       8.2.1. Revenue (US$ Mn) Comparison, By Test Type. 83
       8.2.2. Revenue (US$ Mn) Comparison, By End User. 84
8.3. France Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 85
       8.3.1. Revenue (US$ Mn) Comparison, By Test Type. 858.3.2. Revenue (US$ Mn) Comparison, By End User. 86
8.4. Spain Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 87
       8.4.1. Revenue (US$ Mn) Comparison, By Test Type. 87
       8.4.2. Revenue (US$ Mn) Comparison, By End User. 88
8.5. Italy Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 89
       8.5.1. Revenue (US$ Mn) Comparison, By Test Type. 89
       8.5.2. Revenue (US$ Mn) Comparison, By End User. 90
8.6. Nordic Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 91
       8.6.1. Revenue (US$ Mn) Comparison, By Test Type. 91
       8.6.2. Revenue (US$ Mn) Comparison, By End User. 92

Chapter 9. Japan Blood Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022. 93
9.1. Japan Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 93
       9.1.1. Revenue (US$ Mn) Comparison, By Test Type. 93
       9.1.2. Revenue (US$ Mn) Comparison, By End User. 94

Chapter 10. APEJ Blood Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022. 95
10.1. China Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 95
       10.1.1. Revenue (US$ Mn) Comparison, By Test Type. 95
       10.1.2. Revenue (US$ Mn) Comparison, By End User. 96
10.2. India Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 97
       10.2.1. Revenue (US$ Mn) Comparison, By Test Type. 97
       10.2.2. Revenue (US$ Mn) Comparison, By End User. 98
10.3. Malaysia Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 99
       10.3.1. Revenue (US$ Mn) Comparison, By Test Type. 99
       10.3.2. Revenue (US$ Mn) Comparison, By End User. 100
10.4. Thailand Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 101
       10.4.1. Revenue (US$ Mn) Comparison, By Test Type. 101
       10.4.2. Revenue (US$ Mn) Comparison, By End User. 102
10.5. Singapore Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 103
       10.5.1. Revenue (US$ Mn) Comparison, By Test Type. 103
       10.5.2. Revenue (US$ Mn) Comparison, By End User. 104
10.6. Australia Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 105
       10.6.1. Revenue (US$ Mn) Comparison, By Test Type. 105
       10.6.2. Revenue (US$ Mn) Comparison, By End User. 106

Chapter 11. MEA Blood Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022. 107
11.1. GCC Countries Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 107
       11.1.1. Revenue (US$ Mn) Comparison, By Test Type. 107
       11.1.2. Revenue (US$ Mn) Comparison, By End User. 108
11.2. South Africa Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 109
       11.2.1. Revenue (US$ Mn) Comparison, By Test Type. 109
       11.2.2. Revenue (US$ Mn) Comparison, By End User. 110
11.3. Nigeria Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 111
       11.3.1. Revenue (US$ Mn) Comparison, By Test Type. 111
       11.3.2. Revenue (US$ Mn) Comparison, By End User. 112
11.4. Israel Blood Cancer Diagnostics Market Size and Forecast, 2012-2022. 113
       11.4.1. Revenue (US$ Mn) Comparison, By Test Type. 113
       11.4.2. Revenue (US$ Mn) Comparison, By End User. 114

Chapter 12. Company Profiles. 115
12.1. Abbott Laboratories. 115
       12.1.1. Company Overview. 115
       12.1.2. Product Overview. 116
       12.1.3. Key Financials. 116
       12.1.4. Key Developments. 116
12.2. Roche Holding AG.. 117
       12.2.1. Company Overview. 117
       12.2.2. Product Overview. 117
       12.2.3. Key Financials. 118
12.3. Thermo Fisher Scientific Inc.. 119
       12.3.1. Company Overview. 119
       12.3.2. Product Overview. 119
       12.3.3. Key Financials. 120
       12.3.4. SWOT Analysis. 120
       12.3.5. Key Developments. 121
12.4. Laboratory Corporation Of America Holdings. 122
       12.4.1. Company Overview. 122
       12.4.2. Product Overview. 122
       12.4.3. Key Financials. 123
12.5. Luminex Corporation. 124
       12.5.1. Company Overview. 124
       12.5.2. Product Overview. 124
       12.5.3. Key Financials. 125
12.6. Myriad Genetics Inc. 126
       12.6.1. Company Overview. 126
       12.6.2. Key Financials. 127
       12.6.3. SWOT Analysis. 127
12.7. NanoString Technologies Inc. 131
       12.7.1. Company Overview. 131
       12.7.2. Product Overview. 131
       12.7.3. Key Financials. 131
12.8. NeoGenomics Laboratories, Inc.. 133
       12.8.1. Company Overview. 133
       12.8.2. Key Financials. 133
12.9. Siemens AG. 134
       12.9.1. Company Overview. 134
       12.9.2. Key Financials. 134
       12.9.3. Key Developments. 135
       12.9.4. SWOT Analysis. 135
12.10. Quest Diagnostics Incorporated. 136
       12.10.1. Company Overview. 136
       12.10.2. Product Overview. 136
       12.10.3. Key Financials. 137
       12.10.4. SWOT Analysis. 137
12.11. QIAGEN N.V.. 140
       12.11.1. Company Overview. 140
       12.11.2. Product Overview. 140
       12.11.3. Key Financials. 141
12.12. Agilent Technologies. 142
       12.12.1. Company Overview. 142
       12.12.2. Product Overview. 142
       12.12.3. Key Financials. 142
       12.12.4. Key Developments. 143
       12.12.5. SWOT Analysis. 143
12.13. Biotheranostics, Inc. 144
       12.13.1. Company Overview. 144
       12.13.2. Product Overview. 144
12.14. Almac Group Limited. 145
       12.14.1. Company Overview. 145
       12.14.2. Product Overview. 145
12.15. GeneNews Limited. 146
       12.15.1. Company Overview. 146
       12.15.2. Product Overview. 146

Chapter 13. Disclaimer and Contact information. 147

TABLE 1 Global Blood Cancer Diagnostics Market Value (US$ Mn), 2012-2016 24
TABLE 2 Global Blood Cancer Diagnostics Market Value (US$ Mn), 2017-2022 25
TABLE 3 Global Blood Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2015-2022 27
TABLE 4 Global CBC Tests Segment Value (US$ Mn), By Region 2012-2016 30
TABLE 5 Global CBC Tests Segment Value (US$ Mn), By Region 2017-2022 31
TABLE 6 Global CBC Tests Segment Market Share, By Region 2012-2016 32
TABLE 7 Global CBC Tests Segment Market Share, By Region 2017-2022 32
TABLE 8 Global CBC Tests Segment Y-o-Y, By Region 2015-2022 32
TABLE 9 Global CTC Tests Segment Value (US$ Mn), By Region 2012-2016 33
TABLE 10 Global CTC Tests Segment Value (US$ Mn), By Region 2017-2022 34
TABLE 11 Global CTC Tests Segment Market Share, By Region 2012-2016 35
TABLE 12 Global CTC Tests Segment Market Share, By Region 2017-2022 35
TABLE 13 Global CTC Tests Segment Y-o-Y, By Region 2015-2022 35
TABLE 14 Global Blood Protein Testing Segment Value (US$ Mn), By Region 2012-2016 36
TABLE 15 Global Blood Protein Testing Segment Value (US$ Mn), By Region 2017-2022 37
TABLE 16 Global Blood Protein Testing Segment Market Share, By Region 2012-2016 38
TABLE 17 Global Blood Protein Testing Segment Market Share, By Region 2017-2022 38
TABLE 18 Global Blood Protein Testing Segment Y-o-Y, By Region 2015-2022 38
TABLE 19 Global Liquid Biopsy Segment Value (US$ Mn), By Region 2012-2016 39
TABLE 20 Global Liquid Biopsy Segment Value (US$ Mn), By Region 2017-2022 40
TABLE 21 Global Liquid Biopsy Segment Market Share, By Region 2012-2016 41
TABLE 22 Global Liquid Biopsy Segment Market Share, By Region 2017-2022 41
TABLE 23 Global Liquid Biopsy Segment Y-o-Y, By Region 2015-2022 41
TABLE 24 Global Bone Marrow Biopsy Segment Value (US$ Mn), By Region 2012-2016 42
TABLE 25 Global Bone Marrow Biopsy Segment Value (US$ Mn), By Region 2017-2022 43
TABLE 26 Global Bone Marrow Biopsy Segment Market Share, By Region 2012-2016 44
TABLE 27 Global Bone Marrow Biopsy Segment Market Share, By Region 2017-2022 44
TABLE 28 Global Bone Marrow Biopsy Segment Y-o-Y, By Region 2015-2022 44
TABLE 29 Global Others Segment Value (US$ Mn), By Region 2012-2016 45
TABLE 30 Global Others Segment Value (US$ Mn), By Region 2017-2022 46
TABLE 31 Global Others Segment Market Share, By Region 2012-2016 47
TABLE 32 Global Others Segment Market Share, By Region 2017-2022 47
TABLE 33 Global Others Segment Y-o-Y, By Region 2015-2022 47
TABLE 34 Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2012-2016 49
TABLE 35 Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2017-2022 50
TABLE 36 Global Hospital Associated Labs Segment Market Share, By Region 2012-2016 51
TABLE 37 Global Hospital Associated Labs Segment Market Share, By Region 2017-2022 51
TABLE 38 Global Hospital Associated Labs Segment Y-o-Y, By Region 2015-2022 51
TABLE 39 Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2012-2016 52
TABLE 40 Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2017-2022 53
TABLE 41 Global Independent Diagnostic Laboratories Segment Market Share, By Region 2012-2016 54
TABLE 42 Global Independent Diagnostic Laboratories Segment Market Share, By Region 2017-2022 54
TABLE 43 Global Independent Diagnostic Laboratories Segment Y-o-Y, By Region 2015-2022 54
TABLE 44 Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2012-2016 55
TABLE 45 Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2017-2022 56
TABLE 46 Global Cancer Research Institutes Segment Market Share, By Region 2012-2016 57
TABLE 47 Global Cancer Research Institutes Segment Market Share, By Region 2017-2022 57
TABLE 48 Global Cancer Research Institutes Segment Y-o-Y, By Region 2015-2022 57
TABLE 49 Global Others Segment Value (US$ Mn), By Region 2012-2016 58
TABLE 50 Global Others Segment Value (US$ Mn), By Region 2017-2022 59
TABLE 51 Global Others Segment Market Share, By Region 2012-2016 60
TABLE 52 Global Others Segment Market Share, By Region 2017-2022 60
TABLE 53 Global Others Segment Y-o-Y, By Region 2015-2022 60
TABLE 54 North America Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 62
TABLE 55 North America Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 63
TABLE 56 North America Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 64
TABLE 57 North America Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 64
TABLE 58 Latin America Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 66
TABLE 59 Latin America Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 66
TABLE 60 Latin America Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 67
TABLE 61 Latin America Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 68
TABLE 62 Europe Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 69
TABLE 63 Europe Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 70
TABLE 64 Europe Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 71
TABLE 65 Europe Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 72
TABLE 66 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 73
TABLE 67 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 73
TABLE 68 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 74
TABLE 69 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 75
TABLE 70 APEJ Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 76
TABLE 71 APEJ Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 77
TABLE 72 APEJ Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 78
TABLE 73 APEJ Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 78
TABLE 74 MEA Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 79
TABLE 75 MEA Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 80
TABLE 76 MEA Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 81
TABLE 77 MEA Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 82
TABLE 78 US Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 83
TABLE 79 US Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 83
TABLE 80 US Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 84
TABLE 81 US Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 84
TABLE 82 Canada Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 85
TABLE 83 Canada Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 85
TABLE 84 Canada Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 86
TABLE 85 Canada Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 86
TABLE 86 Brazil Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 87
TABLE 87 Brazil Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 87
TABLE 88 Brazil Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 88
TABLE 89 Brazil Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 88
TABLE 90 Mexico Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 89
TABLE 91 Mexico Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 89
TABLE 92 Mexico Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 90
TABLE 93 Mexico Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 90
TABLE 94 Argentina Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 91
TABLE 95 Argentina Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 91
TABLE 96 Argentina Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 92
TABLE 97 Argentina Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 92
TABLE 98 Germany Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 93
TABLE 99 Germany Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 93
TABLE 100 Germany Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 94
TABLE 101 Germany Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 94
TABLE 102 UK Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 95
TABLE 103 UK Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 95
TABLE 104 UK Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 96
TABLE 105 UK Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 96
TABLE 106 France Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 97
TABLE 107 France Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 97
TABLE 108 France Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 98
TABLE 109 France Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 98
TABLE 110 Spain Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 99
TABLE 111 Spain Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 99
TABLE 112 Spain Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 100
TABLE 113 Spain Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 100
TABLE 114 Italy Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 101
TABLE 115 Italy Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 101
TABLE 116 Italy Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 102
TABLE 117 Italy Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 102
TABLE 118 Nordic Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 103
TABLE 119 Nordic Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 103
TABLE 120 Nordic Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 104
TABLE 121 Nordic Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 104
TABLE 122 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 105
TABLE 123 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 105
TABLE 124 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 106
TABLE 125 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 106
TABLE 126 China Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 107
TABLE 127 China Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 107
TABLE 128 China Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 108
TABLE 129 China Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 108
TABLE 130 India Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 109
TABLE 131 India Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 109
TABLE 132 India Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 110
TABLE 133 India Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 110
TABLE 134 Malaysia Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 111
TABLE 135 Malaysia Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 111
TABLE 136 Malaysia Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 112
TABLE 137 Malaysia Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 112
TABLE 138 Thailand Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 113
TABLE 139 Thailand Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 113
TABLE 140 Thailand Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 114
TABLE 141 Thailand Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 114
TABLE 142 Singapore Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 115
TABLE 143 Singapore Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 115
TABLE 144 Singapore Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 116
TABLE 145 Singapore Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 116
TABLE 146 Australia Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 117
TABLE 147 Australia Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 117
TABLE 148 Australia Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 118
TABLE 149 Australia Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 118
TABLE 150 GCC Countries Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 119
TABLE 151 GCC Countries Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 119
TABLE 152 GCC Countries Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 120
TABLE 153 GCC Countries Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 120
TABLE 154 South Africa Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 121
TABLE 155 South Africa Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 121
TABLE 156 South Africa Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 122
TABLE 157 South Africa Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 122
TABLE 158 Nigeria Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 123
TABLE 159 Nigeria Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 123
TABLE 160 Nigeria Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 124
TABLE 161 Nigeria Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 124
TABLE 162 Israel Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 125
TABLE 163 Israel Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 125
TABLE 164 Israel Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 126
TABLE 165 Israel Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 126

FIG. 1 Global Blood Cancer Diagnostics Market Value (US$ Mn), 2012-2016 
FIG. 2 Global Blood Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017-2022 17
FIG. 3 Global Blood Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2015-2022 19
FIG. 4 Global CBC Tests Segment Market Value (US$ Mn) By Region, 2012-2016 22
FIG. 5 Global CBC Tests Segment Market Value (US$ Mn) By Region, 2017-2022 23
FIG. 6 Global CBC Tests Segment Y-o-Y Growth Rate, By Region, 2015-2022 25
FIG. 7 Global CTC Tests Segment Market Value (US$ Mn) By Region, 2012-2016 25
FIG. 8 Global CTC Tests Segment Market Value (US$ Mn) By Region, 2017-2022 26
FIG. 9 Global CTC Tests Segment Y-o-Y Growth Rate, By Region, 2015-2022 28
FIG. 10 Global Blood Protein Testing Segment Market Value (US$ Mn) By Region, 2012-2016 28
FIG. 11 Global Blood Protein Testing Segment Market Value (US$ Mn) By Region, 2017-2022 29
FIG. 12 Global Blood Protein Testing Segment Y-o-Y Growth Rate, By Region, 2015-2022 31
FIG. 13 Global Liquid Biopsy Segment Market Value (US$ Mn) By Region, 2012-2016 31
FIG. 14 Global Liquid Biopsy Segment Market Value (US$ Mn) By Region, 2017-2022 32
FIG. 15 Global Liquid Biopsy Segment Y-o-Y Growth Rate, By Region, 2015-2022 34
FIG. 16 Global Bone Marrow Biopsy Segment Market Value (US$ Mn) By Region, 2012-2016 34
FIG. 17 Global Bone Marrow Biopsy Segment Market Value (US$ Mn) By Region, 2017-2022 35
FIG. 18 Global Bone Marrow Biopsy Segment Y-o-Y Growth Rate, By Region, 2015-2022 37
FIG. 19 Global Others Segment Market Value (US$ Mn) By Region, 2012-2016 37
FIG. 20 Global Others Segment Market Value (US$ Mn) By Region, 2017-2022 38
FIG. 21 Global Others Segment Y-o-Y Growth Rate, By Region, 2015-2022 40
FIG. 22 Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2012-2016 41
FIG. 23 Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2017-2022 42
FIG. 24 Global Hospital Associated Labs Segment Y-o-Y Growth Rate, By Region, 2015-2022 44
FIG. 25 Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2012-2016 44
FIG. 26 Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2017-2022 45
FIG. 27 Global Independent Diagnostic Laboratories Segment Y-o-Y Growth Rate, By Region, 2015-2022 47
FIG. 28 Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2012-2016 47
FIG. 29 Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2017-2022 48
FIG. 30 Global Cancer Research Institutes Segment Y-o-Y Growth Rate, By Region, 2015-2022 50
FIG. 31 Global Others Segment Market Value (US$ Mn) By Region, 2012-2016 50
FIG. 32 Global Others Segment Market Value (US$ Mn) By Region, 2017-2022 51
FIG. 33 Global Others Segment Y-o-Y Growth Rate, By Region, 2015-2022 53
FIG. 34 North America Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 54
FIG. 35 North America Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 55
FIG. 36 North America Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 56
FIG. 37 North America Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 57
FIG. 38 Latin America Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 58
FIG. 39 Latin America Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 59
FIG. 40 Latin America Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 60
FIG. 41 Latin America Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 60
FIG. 42 Europe Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 62
FIG. 43 Europe Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 62
FIG. 44 Europe Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 63
FIG. 45 Europe Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 64
FIG. 46 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 65
FIG. 47 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 66
FIG. 48 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 67
FIG. 49 Japan Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 67
FIG. 50 APEJ Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 68
FIG. 51 APEJ Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 69
FIG. 52 APEJ Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 70
FIG. 53 APEJ Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 71
FIG. 54 MEA Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 72
FIG. 55 MEA Blood Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 72
FIG. 56 MEA Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 73
FIG. 57 MEA Blood Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 74

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Benefits of Becoming a Fact.MR Client

  • Access to our global market coverage
  • Periodic updates on your sector
  • Exclusive discounts and offers
  • Greater flexibility for customization
  • Quick-research assistance for ad-hoc needs
  • Access to credible insights Fact.MR analyst interactions
  • Access to Fact.MR tools and research to fuel strategy development